Smith-Lemli-Opitz syndrome: Evidence of T93M as a common mutation of Δ7-sterol reductase in Italy and report of three novel mutations

37Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

The Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder of cholesterol biosynthesis characterised by facial dysmorphisms, mental retardation and multiple congenital anomalies. SLOS is caused by mutations of the human Δ7-sterol reductase (DHCR7) gene and, so far, 19 different mutations have been described. Among these, mutations impairing the activity of the C-terminus appear to be the most severe. Here we report the mutational analysis of the DHCR7 gene in nine Italian SLOS patients. The T93M mutation, previously reported in one patient, results the most frequent one (7/18 alleles) in our survey. Furthermore, we identified three novel mutations, two missense mutations (N407Y and E448K), and a 33 bp deletion spanning part of exon 5 and the donor splice site of intron 5.

Cite

CITATION STYLE

APA

De Brasi, D., Esposito, T., Rossi, M., Parenti, G., Sperandeo, M. P., Zuppaldi, A., … Andria, G. (1999). Smith-Lemli-Opitz syndrome: Evidence of T93M as a common mutation of Δ7-sterol reductase in Italy and report of three novel mutations. European Journal of Human Genetics, 7(8), 937–940. https://doi.org/10.1038/sj.ejhg.5200390

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free